schizandrin a has been researched along with Triple Negative Breast Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, G; Liang, G; Liu, Z; Rajamanicham, V; Wang, Y; Xu, S; Xu, X; Yan, T; Zhou, H | 1 |
1 other study(ies) available for schizandrin a and Triple Negative Breast Neoplasms
| Article | Year |
|---|---|
Schisandrin A inhibits triple negative breast cancer cells by regulating Wnt/ER stress signaling pathway.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cyclooctanes; Endoplasmic Reticulum Stress; Female; Humans; Lignans; Mice; Polycyclic Compounds; Schisandra; Triple Negative Breast Neoplasms; Wnt Signaling Pathway; Xenograft Model Antitumor Assays | 2019 |